SG Americas Securities, LLC
Broker-DealerPosition in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1313360
NEW YORK, NY
Position in SUPN
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$19,498,139
+$18,861,979 QoQ
Shares Held
377,213
+2847.0% QoQ
Ownership
0.650%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SG Americas Securities, LLC holds $233,543,492 across 35 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,812,814 | $65,021,117 | |
| 2 | ZTS |
Zoetis Inc.
|
290,332 | $34,320,145 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,179 | $30,824,618 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
780,518 | $23,509,202 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
377,213 | $19,498,139 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
23,113 | $13,705,546 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
710,876 | $8,836,188 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
59,267 | $7,807,834 |
All Filings in SUPN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,498,139 | 377,213 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $636,160 | 12,800 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $494,769 | 10,353 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $675,252 | 21,423 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $578,725 | 17,671 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $390,672 | 10,804 | Shares | Sole | 2025-01-17 | |
| 2024-06-30 | $483,212 | 18,064 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $129,106 | 3,785 | Shares | Sole | 2024-05-06 | |
| 2023-09-30 | $799,502 | 28,999 | Shares | Sole | 2023-10-13 | |
| 2022-12-31 | $445,982 | 12,503 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $329,631 | 9,738 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,313,488 | 45,418 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,858,464 | 57,502 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,367,033 | 81,174 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,392,174 | 52,200 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $321,755 | 10,450 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $201,010 | 7,678 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $207,343 | 8,241 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $451,519 | 21,666 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,293,710 | 54,472 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $396,211 | 22,024 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||